Full text is available at the source.
Circadian Disruption and Prostate Cancer Risk: An Updated Review of Epidemiological Evidences
Disrupted Body Clocks and Risk of Prostate Cancer: Updated Evidence from Population Studies
AI simplified
Abstract
Twelve new studies were identified that evaluate the effects of various circadian disruptors on prostate cancer risk.
- Epidemiologic evidence suggests that disruption of the circadian rhythm may be linked to cancer development.
- Recent research focuses on factors such as night shift work, sleep patterns, and circadian genes in relation to prostate cancer.
- No new studies have been published regarding exposure to light at night and its impact on prostate cancer risk.
- Several hypotheses exist to explain the potential relationship between circadian disruption and cancer.
- Further studies are needed to clarify the role of circadian disruption in prostate cancer risk and to enhance the understanding of different night shift systems and genetic factors.
AI simplified